CI Investments Inc
HAE icon

CI Investments Inc’s Haemonetics HAE Stock Holding History

CI Investments Inc’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95
Closed -$6K – 1317
2025
Q1 		$6K Sell
95
-10
-10% -$680 ﹤0.01% 1262
2024
Q4 		$8K Buy
105
+50
+91% +$4.02K ﹤0.01% 1257
2024
Q3 		$4K Buy
+55
New +$4.44K ﹤0.01% 1256
2024
Q2 		– Sell
-114
Closed -$10K – 1284
2024
Q1 		$10K Buy
+114
New +$8.95K ﹤0.01% 1205
2019
Q4 		– Sell
-4,062
Closed -$512K – 619
2019
Q3 		$512K Buy
+4,062
New +$516K ﹤0.01% 477
2014
Q2 		– Sell
-914,801
Closed -$29.8M – 191
2014
Q1 		$29.8M Buy
914,801
+427,865
+88% +$16.4M 0.31% 82
2013
Q4 		$20.5M Buy
486,936
+286,936
+143% +$11.8M 0.22% 87
2013
Q3 		$7.98M Buy
+200,000
New +$8.39M 0.09% 121

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CI Investments Inc's HAE Position: Q2 2025 in Review

CI Investments Inc sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 95 shares — an estimated $6K sold.

CI Investments Inc first reported a position in HAE in Q3 2013 and held it in 8 quarters. The position peaked at $29.8M in Q1 2014. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • CI Investments Inc reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 95 Haemonetics shares in Q2 2025, an estimated $6K.
  • CI Investments Inc first reported a position in Haemonetics in Q3 2013 and held it in 8 quarters.
  • CI Investments Inc's Haemonetics position peaked at $29.8M in Q1 2014.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.